As a contract design and manufacturing organization (CDMO), we work closely with our customers to deliver proven, highly engineered products that help millions of people live healthier, more productive lives.
Our 60+ years of expertise and the backing of one of the largest privately held companies in the world allow us to focus on long-term, mutually beneficial solutions for our customers, employees and communities.
The engineers at Phillips Medisize, a privately owned, global CDMO, collaborate with industry leaders and innovators to design and manufacture drug delivery systems, medical devices and diagnostic tools that save and improve the quality of life for millions of patients annually.
With our dedicated team of 6,000+ employees and 29 development and manufacturing sites across three continents, we put the patient at the center of all we do, knowing that every decision is critical to a healthcare provider and their patients somewhere in the world.
Phillips Medisize is a Molex company, and Molex—a global electronics brand that serves many sectors, including healthcare—is owned by Koch, one of the largest privately held companies in the world with annual revenue exceeding $125 billion* and 120,000 employees in approximately 60 countries.
Backed by the scale, investment, flexibility and stability of private ownership, Phillips Medisize offers deep design, quality and manufacturing expertise for pharmaceutical, medtech and in vitro diagnostic devices.
Employees worldwide
Years of innovation
Global locations
Countries
Innovation centers
Annual revenue
From discovery to delivery with our customers, we achieve our vision by:
We believe the C in CDMO also represents care – the care we take in engineering products and the care these devices ultimately deliver to patients.
We are privileged to serve our customers in a tailored, highly personalized way. We listen, ask questions and embrace engineering challenges.
While we are proud of the many customers that we have helped in the past 60 years, in just the last few years alone, we have collaborated with:
*Our revenues fluctuate with the price of commodities. They have been as high as $125 billion.
